Title |
Vitamin C for preventing and treating the common cold
|
---|---|
Published in |
Cochrane database of systematic reviews, April 1998
|
DOI | 10.1002/14651858.cd000980 |
Pubmed ID | |
Authors |
Douglas, RM, Chalker, EB, Treacy, B |
Abstract |
The role of oral ascorbic acid (vitamin C) in the prevention and treatment of colds remains controversial despite many controlled trials. There have also been a number of efforts to synthesize and/or overview the results of these trials, and controversy over what these overviews tell us. The objective of this review was to answer the following two questions: (1) Does regular high dosage supplementation with vitamin C reduce the incidence of colds? (2) Does taking vitamin C in high doses at the onset of a cold have a therapeutic effect? This review currently deals only with published trials from two previously published reviews by Kleijnen 1989 and Hemila 1992. Randomised and non-randomised trials of vitamin C taken to prevent or treat the common cold. Two reviewers independently extracted data and assessed trial quality. Thirty trials were included. The quality of the included trials was variable. Vitamin C in doses as high as one gram daily for several winter months, had no consistent beneficial effect on incidence of the common cold. For both preventive and therapeutic trials, there was a consistently beneficial but generally modest therapeutic effect on duration of cold symptoms. This effect was variable, ranging from -0.07% to a 39% reduction in symptom days. The weighted difference across all of the studies revealed a reduction of a little less than half a symptom day per cold episode, representing an 8% to 9% reduction in symptom days. There was no clear indication of the relative benefits of different regimes or vitamin C doses. However in trials that tested vitamin C after cold symptoms occurred, there was some evidence that a large dose produced greater benefits than lower doses. Long term daily supplementation with vitamin C in large doses daily does not appear to prevent colds. There appears to be a modest benefit in reducing duration of cold symptoms from ingestion of relatively high doses of vitamin C. The relation of dose to therapeutic benefit needs further exploration. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 18 | 14% |
United States | 6 | 5% |
Saudi Arabia | 5 | 4% |
Argentina | 4 | 3% |
Brazil | 3 | 2% |
Spain | 3 | 2% |
Ireland | 2 | 2% |
Ecuador | 2 | 2% |
Canada | 2 | 2% |
Other | 14 | 11% |
Unknown | 71 | 55% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 122 | 94% |
Practitioners (doctors, other healthcare professionals) | 5 | 4% |
Scientists | 2 | 2% |
Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Unknown | 88 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 17 | 19% |
Student > Master | 11 | 12% |
Other | 10 | 11% |
Researcher | 9 | 10% |
Librarian | 6 | 7% |
Other | 8 | 9% |
Unknown | 28 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 15 | 17% |
Agricultural and Biological Sciences | 13 | 15% |
Nursing and Health Professions | 7 | 8% |
Biochemistry, Genetics and Molecular Biology | 6 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 6% |
Other | 15 | 17% |
Unknown | 28 | 31% |